The Parathyroid market is a subset of the Endocrinology market, which focuses on the diagnosis and treatment of diseases related to hormones and the endocrine system. Parathyroid disorders are caused by an imbalance of hormones produced by the parathyroid glands, which are located in the neck and regulate calcium levels in the body. Treatment for parathyroid disorders typically involves surgery to remove or reduce the size of the affected gland, or medication to restore hormone balance.
In recent years, advances in technology have enabled the development of new treatments for parathyroid disorders, such as minimally invasive procedures and targeted drug therapies. These treatments have improved patient outcomes and reduced the risk of complications.
Companies in the Parathyroid market include Abbott Laboratories, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
